Theravance Biopharma Inc Capital Reinvestment Ratio
Theravance Biopharma Inc capital reinvestment ratio. Theravance Biopharma Inc (TBPH) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($208.07 Million) in capital expenditures ($34.00K). Check how aggressively does Theravance Biopharma Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Theravance Biopharma Inc (2025–2025)
Capital reinvestment ratio of Theravance Biopharma Inc from 2025 to 2025. This chart tracks Theravance Biopharma Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Theravance Biopharma Inc to track the company's year-over-year net asset growth rate.
Theravance Biopharma Inc Capital Reinvestment Ratio by Year (2025–2025)
Theravance Biopharma Inc capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Theravance Biopharma Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $238.54 Million | $42.00K | — |